AR048460A1 - Tratamiento de la funcion respiratoria alterada con gaboxadol - Google Patents

Tratamiento de la funcion respiratoria alterada con gaboxadol

Info

Publication number
AR048460A1
AR048460A1 ARP050101300A ARP050101300A AR048460A1 AR 048460 A1 AR048460 A1 AR 048460A1 AR P050101300 A ARP050101300 A AR P050101300A AR P050101300 A ARP050101300 A AR P050101300A AR 048460 A1 AR048460 A1 AR 048460A1
Authority
AR
Argentina
Prior art keywords
treatment
gaboxadol
respiratory function
sleep apnea
function altered
Prior art date
Application number
ARP050101300A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR048460A1 publication Critical patent/AR048460A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Metodo para el tratamiento de la alteracion respiratoria en un paciente que sufre apnea del sueno, tal como apnea central del sueno o apnea obstructiva del sueno, que incluye la administracion de una cantidad efectiva de gaboxadol por día al paciente mencionado. Composicion farmacéutica.
ARP050101300A 2004-04-02 2005-04-01 Tratamiento de la funcion respiratoria alterada con gaboxadol AR048460A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200400540 2004-04-02

Publications (1)

Publication Number Publication Date
AR048460A1 true AR048460A1 (es) 2006-04-26

Family

ID=36608890

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101300A AR048460A1 (es) 2004-04-02 2005-04-01 Tratamiento de la funcion respiratoria alterada con gaboxadol

Country Status (6)

Country Link
KR (1) KR20070010136A (es)
CN (1) CN1942185A (es)
AR (1) AR048460A1 (es)
EA (1) EA200601853A1 (es)
IL (1) IL178289A0 (es)
ZA (1) ZA200607427B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3324961A4 (en) * 2015-07-17 2019-03-13 Ovid Therapeutics, Inc. METHOD FOR TREATING DEVELOPMENT DISORDERS WITH GABOXADOL
JP2020529440A (ja) * 2017-08-04 2020-10-08 オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 糖尿病および関連する状態の処置におけるガボキサドールの使用
KR20210110585A (ko) 2018-11-21 2021-09-08 썰테고 테라퓨틱스 아이엔씨. 자살의 위험을 감소시키고 우울증의 신속한 완화를 위한 가복사돌

Also Published As

Publication number Publication date
CN1942185A (zh) 2007-04-04
EA200601853A1 (ru) 2007-02-27
ZA200607427B (en) 2009-02-25
IL178289A0 (en) 2007-03-08
KR20070010136A (ko) 2007-01-22

Similar Documents

Publication Publication Date Title
IL201479A (en) Use of tapentadol for the preparation of pain medication
UA109878C2 (uk) Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти)
TN2010000122A1 (en) Compounds and compositions as modulators of gpr119 activity
MX2010002498A (es) Metodos para tratar o prevenir la infeccion del tracto respiratorio que comprende la administracion de colecalciferol.
MX2009009491A (es) Compuestos y composiciones como moduladores de la actividad del gpr119.
ECSP099556A (es) Nuevos métodos
CO6361917A2 (es) Tratamiento de la diabetes en pacientes con control glucemico insuficiente a pesar de la terapia con un farmaco oral o no oral antidiabetico
MX2009013989A (es) Terapia en combinacion para depresion.
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
BR112015022465A2 (pt) método para tratamento não-tóxico para síndrome de abstinência de drogas
MX2010002736A (es) Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear.
IN2012DN02471A (es)
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
NZ595364A (en) TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION
AR079000A1 (es) Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas
MX355015B (es) Uso de hidroxamatos de indolilo e indolinilo para tratar insuficiencia cardiaca o lesión neuronal.
AR048460A1 (es) Tratamiento de la funcion respiratoria alterada con gaboxadol
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
EA201170874A1 (ru) Новое применение фибратов
UA44344U (ru) Способ интубации слёзоотводных путей при травматических повреждениях средней зоны лица
UA44342U (ru) Способ восстановления слёзоотводных путей при травматических повреждениях средней зоны лица
UA34817U (ru) Способ медицинской реабилитации больных с синдромом повышенной усталости на фоне хронического тонзиллита
UA109259C2 (uk) Способи і композиції для лікування медичних станів, пов'язаних із щитовидною залозою, за допомогою відновлених фолатів
SG163512A1 (en) Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion

Legal Events

Date Code Title Description
FB Suspension of granting procedure